Medgenics (MDGN)

[BollixMeArse]

Kudos to the new management for choosing the right path!

Just read that "Alexion Pharma takes out Synageva BioPharma for $230 per share" This is a huge premium for a company that specializes in rare diseases.

Thanks to the new management, Medgenics is now a company that specializes in rare and orphan diseases...... and with the agreement with CHOP that pipeline will only grow.

As always, this is just my opinion and judging by the lack of any posts on this board I guess there is no interest by the retail investor in this stock!

----
"It's not what you look at that matters, it's what you see"
Henry David Thoreau
----